{"id":"https://openalex.org/W2809293239","doi":"https://doi.org/10.1093/neuonc/noy059.459","title":"MBRS-14. REGULATION OF MEDULLOBLASTOMA IMMUNOGENICITY BY TP53 AND TNF ALPHA","display_name":"MBRS-14. REGULATION OF MEDULLOBLASTOMA IMMUNOGENICITY BY TP53 AND TNF ALPHA","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2809293239","doi":"https://doi.org/10.1093/neuonc/noy059.459","mag":"2809293239"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noy059.459","doi":"https://doi.org/10.1093/neuonc/noy059.459","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy059.459","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_2/i131/24838681/noy059.459.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_2/i131/24838681/noy059.459.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046893582","display_name":"Alexandra Garancher","orcid":"https://orcid.org/0000-0001-5779-2860","observed_orcids":["https://orcid.org/0000-0001-5779-2860"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Garancher","raw_affiliation_strings":["Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA","institution_ids":["https://openalex.org/I188891513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103198718","display_name":"Hiromichi Suzuki","orcid":"https://orcid.org/0000-0002-8858-0294","observed_orcids":["https://orcid.org/0000-0002-8858-0294"]},"institutions":[{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Hiromichi Suzuki","raw_affiliation_strings":["Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040595262","display_name":"Vijay Ramaswamy","orcid":"https://orcid.org/0000-0002-6557-895X","observed_orcids":["https://orcid.org/0000-0002-6557-895X"]},"institutions":[{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vijay Ramaswamy","raw_affiliation_strings":["Division of Haematology/Oncology and Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology/Oncology and Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100644772","display_name":"Michael D. Taylor","orcid":"https://orcid.org/0000-0001-7009-3466","observed_orcids":["https://orcid.org/0000-0001-7009-3466","https://orcid.org/0009-0001-7181-1906"]},"institutions":[{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael D Taylor","raw_affiliation_strings":["Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2801317318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066651467","display_name":"Robert J. Wechsler\u2010Reya","orcid":"https://orcid.org/0000-0002-7463-8352","observed_orcids":["https://orcid.org/0000-0002-7463-8352"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J Wechsler-Reya","raw_affiliation_strings":["Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA","institution_ids":["https://openalex.org/I188891513"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"suppl_2","first_page":"i131","last_page":"i131"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.42329999804496765,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.038600001484155655,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medulloblastoma","display_name":"medulloblastoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/group-3-medulloblastoma","display_name":"Group 3 medulloblastoma","score":0.9070000052452087},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.9409999847412109},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.8610000014305115},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tap1","display_name":"TAP1","score":0.8999999761581421},{"id":"https://openalex.org/keywords/erap1","display_name":"ERAP1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.7210000157356262},{"id":"https://openalex.org/keywords/gfi1","display_name":"GFI1","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dominant-negative-p53","display_name":"dominant-negative p53","score":0.902999997138977},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.652999997138977},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/t-cell-recognition","display_name":"T cell recognition","score":0.5529999732971191},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.682841420173645},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.631523072719574},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6307593584060669},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6097127795219421},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5917888879776001},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5768548846244812},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4995396137237549},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.498584508895874},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.48618167638778687},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4709682762622833},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4641251564025879},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.454490602016449},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13722380995750427},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noy059.459","doi":"https://doi.org/10.1093/neuonc/noy059.459","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy059.459","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_2/i131/24838681/noy059.459.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6012940","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6012940","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noy059.459","doi":"https://doi.org/10.1093/neuonc/noy059.459","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy059.459","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_2/i131/24838681/noy059.459.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2809293239.pdf","grobid_xml":"https://content.openalex.org/works/W2809293239.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2942009355","https://openalex.org/W4313381160","https://openalex.org/W3047026715","https://openalex.org/W2619898489","https://openalex.org/W4404230627","https://openalex.org/W2942050860","https://openalex.org/W4414799703","https://openalex.org/W2940998633","https://openalex.org/W4309013974","https://openalex.org/W2106037940"],"abstract_inverted_index":{"Many":[0],"immunotherapies":[1],"act":[2],"by":[3,24,43,62,73],"enhancing":[4],"the":[5,30,48,219,228],"ability":[6],"of":[7,21,50,64,75,102,132,188,198,213,221],"T":[8,15,44,245],"cells":[9,177],"to":[10,167,237,239,244],"kill":[11],"tumor":[12,31,36,176,189,205],"cells.":[13,45,206],"But":[14],"cell":[16,32,246],"killing":[17],"depends":[18],"on":[19,29,203],"recognition":[20],"antigens":[22],"presented":[23],"Class":[25],"I":[26],"MHC":[27],"(MHC-I)":[28],"surface;":[33],"if":[34],"a":[35,155],"lacks":[37],"MHC-I,":[38],"it":[39],"cannot":[40],"be":[41,234],"recognized":[42],"To":[46,95,170],"study":[47],"efficacy":[49,220],"immunotherapy":[51,238],"for":[52,122],"Group":[53],"3":[54],"medulloblastoma,":[55],"we":[56,99,174],"have":[57],"used":[58,235],"mouse":[59],"models":[60],"driven":[61],"overexpression":[63,74],"Myc":[65,76],"and":[66,77,105,127,144,146,161,201,216],"dominant":[67],"negative":[68],"p53":[69,153],"(\u201cMP":[70],"tumors\u201d),":[71],"or":[72],"Gfi1":[78],"(\u201cMG":[79],"tumors\u201d).":[80],"While":[81],"both":[82],"tumors":[83,90,109,136,164,241],"grow":[84,91],"in":[85,92,158],"immunodeficient":[86],"mice,":[87,215],"only":[88],"MP":[89,108,135,204],"immunocompetent":[93],"mice.":[94],"understand":[96],"this":[97,115,172],"difference,":[98],"analyzed":[100],"expression":[101,197],"immunoregulatory":[103],"molecules,":[104],"found":[106,184],"that":[107,152,162,180,185,230],"completely":[110],"lack":[111,137,142],"surface":[112,147],"MHC-I.":[113,148],"Mechanistically,":[114],"is":[116],"because":[117],"two":[118],"key":[119],"proteins":[120],"required":[121],"MHC-I":[123,202],"trafficking":[124],"-":[125,129],"TAP1":[126,143],"ERAP1":[128],"are":[130,165],"targets":[131],"p53;":[133],"since":[134],"functional":[138],"p53,":[139],"they":[140],"also":[141],"ERAP1,":[145],"These":[149,225],"studies":[150],"suggest":[151],"plays":[154],"critical":[156],"role":[157],"determining":[159],"immunogenicity,":[160],"p53-mutant":[163],"resistant":[166],"immune":[168,222],"attack.":[169,247],"overcome":[171],"resistance,":[173],"treated":[175],"with":[178],"agents":[179],"regulate":[181],"MHC-1.":[182],"We":[183],"low":[186],"doses":[187],"necrosis":[190],"factor":[191],"alpha":[192,210,232],"(TNF":[193],"alpha)":[194],"can":[195],"rescue":[196],"ERAP,":[199],"TAP":[200],"In":[207],"vivo,":[208],"TNF":[209,231],"prolongs":[211],"survival":[212],"tumor-bearing":[214],"markedly":[217],"augments":[218],"checkpoint":[223],"inhibitors.":[224],"results":[226],"raise":[227],"possibility":[229],"could":[233],"prior":[236],"render":[240],"more":[242],"sensitive":[243]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-29T00:00:00"}